Cite
HARVARD Citation
Andorsky, D. et al. (2019). An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma. British journal of haematology. pp. 215-222. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Andorsky, D. et al. (2019). An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma. British journal of haematology. pp. 215-222. [Online].